Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Axsome Therapeutics, Inc (AXSM)

Pharmaceutical Preparations

https://www.axsome.com

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14.

ONE WORLD TRADE CENTER, 22ND FLOOR
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/19/2015

Market Cap

4,139,537,248

Shares Outstanding

47,320,000

Weighted SO

47,319,547

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

INCY --.--%

IMGN --.--%

SRPT --.--%

ACAD --.--%

VKTX --.--%

MDGL --.--%

MCRB --.--%

ICPT --.--%

TGTX --.--%

Beta

1.2540

Last Div

0.0000

Range

55.02-98.4

Chg

0.6300

Avg Vol

673925

Mkt Cap

4139537248

Exch

NASDAQ

Country

US

Phone

212 332 3241

DCF Diff

22.7573

DCF

63.4427

Div Yield

0.0000

P/S

14.2013

EV Multiple

-12.5209

P/FV

39.8895

Div Yield %

0.0000

P/E

-13.2967

PEG

-0.5319

Payout

0.0000

Current Ratio

2.4818

Quick Ratio

2.4002

Cash Ratio

1.6919

DSO

150.6912

DIO

173.8966

Op Cycle

324.5878

DPO

700.8420

CCC

-376.2543

Gross Margin

0.8904

Op Margin

-1.0457

Pretax Margin

-1.0620

Net Margin

-1.0585

Eff Tax Rate

0.0094

ROA

-0.5628

ROE

-1.7448

ROCE

-0.8428

NI/EBT

0.9968

EBT/EBIT

1.0156

EBIT/Rev

-1.0457

Debt Ratio

0.3319

D/E

1.7690

LT Debt/Cap

0.6355

Total Debt/Cap

0.6389

Int Coverage

26.1321

CF/Debt

-0.9205

Equity Multi

5.3302

Rec Turnover

2.4222

Pay Turnover

0.5208

Inv Turnover

2.0989

FA Turnover

42.8976

Asset Turnover

0.5317

OCF/Share

-3.5206

FCF/Share

-3.5317

Cash/Share

6.6352

OCF/Sales

-0.5746

FCF/OCF

1.0032

CF Coverage

-0.9205

ST Coverage

-64.0241

CapEx Coverage

-317.2102

Div&CapEx Cov

-317.2102

P/BV

39.8895

P/B

39.8895

P/S

14.2013

P/E

-13.2967

P/FCF

-24.6379

P/OCF

-24.4957

P/CF

-24.4957

PEG

-0.5319

P/S

14.2013

EV Multiple

-12.5209

P/FV

39.8895

DPS

0.0000

Latest Headlines (EST)

The Motley Fool May 14, 23:30 Is Axsome Therapeutics Stock Worth the Risk? A Comprehensive Analysis GlobeNewswire Inc. May 14, 22:30 Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm GlobeNewswire Inc. Apr 09, 23:05 Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm The Motley Fool Mar 25, 22:47 Why Pharma and Biotech Stocks Got Thrashed on Tuesday The Motley Fool Feb 16, 14:45 This Stock Is Already Up by 55% in 2025: Is It Too Late to Buy? The Motley Fool Nov 17, 12:05 Is It Too Late to Buy Viking Therapeutics Stock? Benzinga Jan 16, 10:00 The Analyst Landscape: 6 Takes On Axsome Therapeutics The Motley Fool Jan 03, 05:20 3 Stocks That Have Turned $50,000 Into More Than $500,000 in Just 5 Years The Motley Fool Jan 02, 08:45 2 Biotech Stocks You Can Buy and Hold for the Next Decade The Motley Fool Jan 01, 06:50 Prediction: These 3 Stocks Will Soar in 2024 The Motley Fool Jan 01, 06:50 Prediction: These 3 Stocks Will Soar in 2024 The Motley Fool Jan 01, 06:50 Prediction: These 3 Stocks Will Soar in 2024 Zacks Investment Research Dec 29, 12:51 Acadia's (ACAD) Nuplazid Sales Drive Growth Amid Competition The Motley Fool Dec 10, 06:56 3 Unstoppable Stocks to Buy Right Now The Motley Fool Nov 22, 05:30 3 Biotech Stocks That Could Be Millionaire Makers Seeking Alpha Nov 20, 00:24 Buy These Stocks; Members Of The Most Hated Tech Sector The Motley Fool Nov 11, 06:50 3 Growth Stocks to Buy Right Now Without Any Hesitation The Motley Fool Nov 11, 06:50 3 Growth Stocks to Buy Right Now Without Any Hesitation The Motley Fool Nov 09, 10:23 3 Healthcare Stocks That Have More Than Doubled in Value Since the Fed Started Raising Interest Rates Benzinga Nov 07, 12:00 Analyst Expectations for Axsome Therapeutics's Future

Revenue Product Segmentation